Federated Hermes
COGT icon

Federated Hermes’s Cogent Biosciences COGT Stock Holding History

Federated Hermes’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
282,979
-2,682
-0.9% -$93.8K 0.02% 667
2026
Q1 		$11M Sell
285,661
-141,121
-33% -$5.21M 0.02% 603
2025
Q4 		$15.2M Buy
426,782
+333,557
+358% +$9.38M 0.03% 516
2025
Q3 		$1.34M Buy
93,225
+93,223
+4,661,150% +$1.1M ﹤0.01% 1062
2025
Q2 		$14 Hold
2
– – ﹤0.01% 2053
2025
Q1 		$12 Sell
2
-2
-50% -$16 ﹤0.01% 2046
2024
Q4 		$31 Buy
4
+1
+33% +$10 ﹤0.01% 2058
2024
Q3 		$32 Buy
3
+2
+200% +$19 ﹤0.01% 2030
2024
Q2 		$8 Buy
+1
New +$8 ﹤0.01% 2004
2023
Q1 		– Sell
-4,305
Closed -$49.8K – 2144
2022
Q4 		$49.8K Buy
4,305
+1,248
+41% +$15.5K ﹤0.01% 1713
2022
Q3 		$46K Buy
+3,057
New +$41.9K ﹤0.01% 1683

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Federated Hermes's COGT Position: Q2 2026 in Review

Federated Hermes reduced its Cogent Biosciences (COGT) stake by 0.94% in Q2 2026, selling an estimated $93.8K and leaving 282,979 shares worth $11M. The position accounts for 0.02% of the portfolio, ranked #667.

Federated Hermes first reported a position in COGT in Q3 2022 and has held it in 11 quarters since. The position peaked at $15.2M in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Federated Hermes held 282,979 shares of Cogent Biosciences worth $11M as of Q2 2026.
  • Federated Hermes sold 2,682 Cogent Biosciences shares in Q2 2026, an estimated $93.8K.
  • Cogent Biosciences made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #667 holding.
  • Federated Hermes first reported a position in Cogent Biosciences in Q3 2022 and has held it in 11 quarters since.
  • Federated Hermes's Cogent Biosciences position peaked at $15.2M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.